Adenine Nucleotide Translocase: From Nucleotide Carrier to a Modulator of Mitochondrial Bioenergetics, Quality Control, and Cellular Communication
Highlights
- Adenine nucleotide translocase (ANT) acts as a mitochondrial multifunctional regulatory hub that stabilizes energetic balance, inner mitochondrial membrane integrity, and quality control beyond its canonical ADP/ATP exchange function.
- ANT integrates mitochondrial stress signals with cellular and systemic responses by regulating redox state, nucleic acid release, innate immune pathways, and intercellular communication through extracellular pathways.
- This framework positions ANT as a context-dependent regulator and organizer that stabilizes mitochondrial function under physiological conditions and coordinates adaptive signaling throughout the whole cell when homeostasis is challenged.
- Preserving or selectively modulating ANT-dependent regulatory interactions may support mitochondrial resilience, cytoprotection, and controlled stress communication.
Abstract
1. Introduction
2. ANT Isoforms: Expression, Regulation, and Functional Bias
3. ANT in Mitochondrial Bioenergetics and Energetic Efficiency
3.1. Differential Contributions of ANT Isoforms to Mitochondrial Bioenergetics
3.2. ANT as a Mitochondrial Uncoupler and Regulator of Oxidative Stress
4. ANT in Mitochondrial Integrity and Quality Control
4.1. ANT and the Mitochondrial Permeability Transition Pore
4.2. ANT at the Interface of Mitochondrial Fusion and Fission

4.3. ANT as a Central Regulator of Mitophagy
5. ANT at the Interface of the Mitochondrial Genome and RNA
5.1. ANT Mutations and mtDNA Instability
5.2. ANT Coordinates Mitochondrial Nucleoid Organization and Stress-Responsive Gene Regulation
6. ANT as a Signaling and Immunometabolic Hub
6.1. ANT as an Integrator of Intracellular Signaling and Stress Responses
6.2. ANT and microRNA-Dependent Regulation
6.3. Cytokine-Dependent Regulation and Inflammasome Control
6.4. ANT as a Mitochondrial RNA Translocon
6.5. ANT in Immune Cell Metabolism and Polarization
7. ANT Beyond Mitochondria: Coupling Mitochondrial Function to Intercellular Communication
7.1. ANT at the Plasma Membrane
7.2. ANT in Extracellular Vesicles
8. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| AKT | Protein kinase B |
| ANT | Adenine nucleotide translocase |
| AP1 | Activator protein 1 |
| ATP | Adenosine triphosphate |
| BAK | BCL2 antagonist/killer |
| BAX | BCL2-associated X protein |
| CD147 | Cluster of differentiation 147 |
| cGAS | Cyclic GMP–AMP synthase |
| CypD | Cyclophilin D |
| DAMP | Damage-associated molecular pattern |
| DRP1 | Dynamin-related protein 1 |
| dsRNA | Double-stranded RNA |
| E2F6 | E2F transcription factor 6 |
| ERK1/2 | Extracellular signal-regulated kinase 1/2 |
| ERα | Estrogen receptor alpha |
| ETS2 | ETS proto-oncogene 2 transcription factor |
| EV | Extracellular vesicle |
| F1FO | F1FO ATP synthase |
| FA | Fatty acid |
| GAS5 | Growth arrest-specific transcript 5 |
| GRBOX | Glycolysis-regulated box |
| GSK-3β | Glycogen synthase kinase 3 beta |
| GSNOR | S-nitrosoglutathione reductase |
| HDL | High-density lipoprotein |
| HER2 | Human epidermal growth factor receptor 2 |
| HIF-1α | Hypoxia-inducible factor 1 alpha |
| HSP27 | Heat shock protein 27 |
| HSP90 | Heat shock protein 90 |
| I/R | Ischemia/reperfusion |
| IFN | Interferon |
| IFN-γ | Interferon gamma |
| IL | Interleukin |
| IMM | Inner mitochondrial membrane |
| ISG | Interferon-stimulated gene |
| LC3 | Microtubule-associated protein 1 light chain 3 |
| M1 | Classically activated macrophage phenotype |
| M2 | Alternatively activated macrophage phenotype |
| MDA5 | Melanoma differentiation-associated protein 5 |
| MDV | Mitochondria-derived vesicle |
| MeCP2 | Methyl-CpG-binding protein 2 |
| MFN1/2 | Mitofusin 1 and 2 |
| MFN2 | Mitofusin 2 |
| miRNA | MicroRNA |
| mPTP | Mitochondrial permeability transition pore |
| mRNA | Messenger RNA |
| MT1-MMP | Membrane type 1 matrix metalloproteinase |
| mtDNA | Mitochondrial DNA |
| mtRNA | Mitochondrial RNA |
| NDPK-D | Nucleoside diphosphate kinase D |
| NFAT | Nuclear factor of activated T cells |
| NF-κB | Nuclear factor kappa B |
| NLRP3 | NLR family pyrin domain-containing 3 |
| NME4 | Nucleoside diphosphate kinase 4 |
| OMM | Outer mitochondrial membrane |
| OPA1 | Optic atrophy protein 1 |
| OXBOX | Oxidative metabolism box |
| OXPHOS | Oxidative phosphorylation |
| PAK6 | p21-activated kinase 6 |
| PHB1 | Prohibitin 1 |
| PHB2 | Prohibitin 2 |
| PI3K | Phosphoinositide 3-kinase |
| PINK1 | PTEN-induced kinase 1 |
| PNPT1 | Polynucleotide phosphorylase 1 |
| PTM | Post-translational modification |
| RB/E2F | Retinoblastoma/E2F complex |
| REBOX | Respiratory element box |
| RIG-I | Retinoic acid-inducible gene I |
| ROS | Reactive oxygen species |
| RyR2 | Ryanodine receptor 2 |
| SERCA2a | Sarcoplasmic/endoplasmic reticulum Ca2+-ATPase 2a |
| SHP2 | SRC homology region 2-containing protein tyrosine phosphatase 2 |
| SIRT4 | Sirtuin 4 |
| Smad | Small mothers against decapentaplegic protein |
| SOCS1 | Suppressor of cytokine signaling 1 |
| SP1 | Specificity protein 1 |
| SRC | SRC family kinase |
| STAT | Signal transducer and activator of transcription |
| STAT1 | Signal transducer and activator of transcription 1 |
| STAT3 | Signal transducer and activator of transcription 3 |
| STING | Stimulator of interferon genes |
| SUV3 | ATP-dependent RNA helicase SUV3 |
| TERC | Telomerase RNA component |
| TFAM | Mitochondrial transcription factor A |
| TGF-β | Transforming growth factor beta |
| TIMM | Translocase of the inner mitochondrial membrane |
| TIMM22 | TIMM22 translocase complex |
| TIMM23 | TIMM23 translocase complex |
| TIMM44 | TIMM44 inner membrane import component |
| TLR4 | Toll-like receptor 4 |
| TNFα | Tumor necrosis factor alpha |
| TOMM | Translocase of the outer mitochondrial membrane |
| TSPO2 | Translocator protein 2 |
| UCP | Uncoupling protein |
| UCP3 | Uncoupling protein 3 |
| USP34 | Ubiquitin-specific peptidase 34 |
| VDAC | Voltage-dependent anion channel |
| VEGF | Vascular endothelial growth factor |
| YY1 | Yin Yang 1 |
| ZNF555 | Zinc finger protein 555 |
| ΔΨm | Mitochondrial membrane potential |
References
- Klingenberg, M. The ADP and ATP transport in mitochondria and its carrier. Biochim. Biophys. Acta 2008, 1778, 1978–2021. [Google Scholar] [CrossRef]
- Pebay-Peyroula, E.; Dahout-Gonzalez, C.; Kahn, R.; Trézéguet, V.; Lauquin, G.J.; Brandolin, G. Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 2003, 426, 39–44. [Google Scholar] [CrossRef] [PubMed]
- Cimadamore-Werthein, C.; King, M.S.; Lacabanne, D.; Pyrihova, E.; Jaiquel Baron, S.; Kunji, E.R. Human mitochondrial carriers of the SLC25 family function as monomers exchanging substrates with a ping-pong kinetic mechanism. EMBO J. 2024, 43, 3450–3465. [Google Scholar] [CrossRef]
- Mishra, G.; Coyne, L.P.; Chen, X.J. Adenine nucleotide carrier protein dysfunction in human disease. IUBMB Life 2023, 75, 911–925. [Google Scholar] [CrossRef]
- Chen, Y.; Wu, L.; Liu, J.; Ma, L.; Zhang, W. Adenine nucleotide translocase: Current knowledge in post-translational modifications, regulations and pathological implications for human diseases. FASEB J. 2023, 37, e22953. [Google Scholar] [CrossRef]
- Frigo, E.; Tommasin, L.; Lippe, G.; Carraro, M.; Bernardi, P. The Haves and Have-Nots: The Mitochondrial Permeability Transition Pore across Species. Cells 2023, 12, 1409. [Google Scholar] [CrossRef]
- Doerner, A.; Pauschinger, M.; Badorff, A.; Noutsias, M.; Giessen, S.; Schulze, K.; Bilger, J.; Rauch, U.; Schultheiss, H.P. Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett. 1997, 414, 258–262. [Google Scholar] [CrossRef]
- Traba, J.; Satrustegui, J.; del Arco, A. Adenine nucleotide transporters in organelles: Novel genes and functions. Cell Mol. Life Sci. 2011, 68, 1183–1206. [Google Scholar] [CrossRef]
- Li, K.; Hodge, J.A.; Wallace, D.C. OXBOX, a positive transcriptional element of the heart-skeletal muscle ADP/ATP translocator gene. J. Biol. Chem. 1990, 265, 20585–20588. [Google Scholar] [CrossRef] [PubMed]
- Chung, A.B.; Stepien, G.; Haraguchi, Y.; Li, K.; Wallace, D.C. Transcriptional control of nuclear genes for the mitochondrial muscle ADP/ATP translocator and the ATP synthase beta subunit. Multiple factors interact with the OXBOX/REBOX promoter sequences. J. Biol. Chem. 1992, 267, 21154–21161. [Google Scholar] [CrossRef] [PubMed]
- Zhang, C.; Jiang, H.; Wang, P.; Liu, H.; Sun, X. Transcription factor NF-kappa B represses ANT1 transcription and leads to mitochondrial dysfunctions. Sci. Rep. 2017, 7, 44708. [Google Scholar] [CrossRef]
- Forlani, G.; Giarda, E.; Ala, U.; Di Cunto, F.; Salani, M.; Tupler, R.; Kilstrup-Nielsen, C.; Landsberger, N. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: Novel hints for Rett syndrome pathogenesis. Hum. Mol. Genet. 2010, 19, 3114–3123. [Google Scholar] [CrossRef] [PubMed]
- Kim, E.; Rich, J.; Karoutas, A.; Tarlykov, P.; Cochet, E.; Malysheva, D.; Mamchaoui, K.; Ogryzko, V.; Pirozhkova, I. ZNF555 protein binds to transcriptional activator site of 4qA allele and ANT1: Potential implication in Facioscapulohumeral dystrophy. Nucleic Acids Res. 2015, 43, 8227–8242. [Google Scholar] [CrossRef] [PubMed]
- Law, A.K.; Gupta, D.; Levy, S.; Wallace, D.C.; McKeon, R.J.; Buck, C.R. TGF-beta1 induction of the adenine nucleotide translocator 1 in astrocytes occurs through Smads and Sp1 transcription factors. BMC Neurosci. 2004, 5, 1. [Google Scholar] [CrossRef][Green Version]
- Rottensteiner, H.; Palmieri, L.; Hartig, A.; Hamilton, B.; Ruis, H.; Erdmann, R.; Gurvitz, A. The peroxisomal transporter gene ANT1 is regulated by a deviant oleate response element (ORE): Characterization of the signal for fatty acid induction. Biochem. J. 2002, 365, 109–117. [Google Scholar] [CrossRef][Green Version]
- Giraud, S.; Bonod-Bidaud, C.; Wesolowski-Louvel, M.; Stepien, G. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J. Mol. Biol. 1998, 281, 409–418. [Google Scholar] [CrossRef]
- Slim, R.; Levilliers, J.; Lüdecke, H.J.; Claussen, U.; Nguyen, V.C.; Gough, N.M.; Horsthemke, B.; Petit, C. A human pseudoautosomal gene encodes the ANT3 ADP/ATP translocase and escapes X-inactivation. Genomics 1993, 16, 26–33. [Google Scholar] [CrossRef]
- Dupont, P.Y.; Stepien, G. Computational analysis of the transcriptional regulation of the adenine nucleotide translocator isoform 4 gene and its role in spermatozoid glycolytic metabolism. Gene 2011, 487, 38–45. [Google Scholar] [CrossRef]
- Rodić, N.; Oka, M.; Hamazaki, T.; Murawski, M.R.; Jorgensen, M.; Maatouk, D.M.; Resnick, J.L.; Li, E.; Terada, N. DNA methylation is required for silencing of ant4, an adenine nucleotide translocase selectively expressed in mouse embryonic stem cells and germ cells. Stem Cells 2005, 23, 1314–1323. [Google Scholar] [CrossRef] [PubMed]
- Kehoe, S.M.; Oka, M.; Hankowski, K.E.; Reichert, N.; Garcia, S.; McCarrey, J.R.; Gaubatz, S.; Terada, N. A conserved E2F6-binding element in murine meiosis-specific gene promoters. Biol. Reprod. 2008, 79, 921–930. [Google Scholar] [CrossRef]
- Graham, B.H.; Waymire, K.G.; Cottrell, B.; Trounce, I.A.; MacGregor, G.R.; Wallace, D.C. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat. Genet. 1997, 16, 226–234. [Google Scholar] [CrossRef]
- Kokoszka, J.E.; Waymire, K.G.; Flierl, A.; Sweeney, K.M.; Angelin, A.; MacGregor, G.R.; Wallace, D.C. Deficiency in the mouse mitochondrial adenine nucleotide translocator isoform 2 gene is associated with cardiac noncompaction. Biochim. Biophys. Acta 2016, 1857, 1203–1212. [Google Scholar] [CrossRef]
- Jang, J.Y.; Lee, C.E. Mitochondrial adenine nucleotide translocator 3 is regulated by IL-4 and IFN-gamma via STAT-dependent pathways. Cell Immunol. 2003, 226, 11–19. [Google Scholar] [CrossRef]
- Brower, J.V.; Lim, C.H.; Jorgensen, M.; Oh, S.P.; Terada, N. Adenine nucleotide translocase 4 deficiency leads to early meiotic arrest of murine male germ cells. Reproduction 2009, 138, 463–470. [Google Scholar] [CrossRef] [PubMed]
- Stepien, G.; Torroni, A.; Chung, A.B.; Hodge, J.A.; Wallace, D.C. Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J. Biol. Chem. 1992, 267, 14592–14597. [Google Scholar] [CrossRef]
- Gavaldà-Navarro, A.; Mampel, T.; Viñas, O. Changes in the expression of the human adenine nucleotide translocase isoforms condition cellular metabolic/proliferative status. Open Biol. 2016, 6, 150108. [Google Scholar] [CrossRef] [PubMed]
- Pan, T.; Yang, B.; Yao, S.; Wang, R.; Zhu, Y. Exploring the multifaceted role of adenosine nucleotide translocase 2 in cellular and disease processes: A comprehensive review. Life Sci. 2024, 351, 122802. [Google Scholar] [CrossRef]
- Dorner, A.; Giessen, S.; Gaub, R.; Grosse Siestrup, H.; Schwimmbeck, P.L.; Hetzer, R.; Poller, W.; Schultheiss, H.P. An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy. Eur. J. Heart Fail. 2006, 8, 81–89. [Google Scholar] [CrossRef] [PubMed]
- Flierl, A.; Schriner, S.E.; Hancock, S.; Coskun, P.E.; Wallace, D.C. The mitochondrial adenine nucleotide transporters in myogenesis. Free Radic. Biol. Med. 2022, 188, 312–327. [Google Scholar] [CrossRef]
- Gouriou, Y.; Alam, M.R.; Harhous, Z.; Crola Da Silva, C.; Baetz, D.B.; Badawi, S.; Lefai, E.; Rieusset, J.; Durand, A.; Harisseh, R.; et al. ANT2-Mediated ATP Import into Mitochondria Protects against Hypoxia Lethal Injury. Cells 2020, 9, 2542. [Google Scholar] [CrossRef]
- Vyssokikh, M.Y.; Katz, A.; Rueck, A.; Wuensch, C.; Dörner, A.; Zorov, D.B.; Brdiczka, D. Adenine nucleotide translocator isoforms 1 and 2 are differently distributed in the mitochondrial inner membrane and have distinct affinities to cyclophilin D. Biochem. J. 2001, 358, 349–358. [Google Scholar] [CrossRef] [PubMed]
- Letts, J.A.; Fiedorczuk, K.; Sazanov, L.A. The architecture of respiratory supercomplexes. Nature 2016, 537, 644–648. [Google Scholar] [CrossRef]
- Nesterov, S.; Chesnokov, Y.; Kamyshinsky, R.; Panteleeva, A.; Lyamzaev, K.; Vasilov, R.; Yaguzhinsky, L. Ordered Clusters of the Complete Oxidative Phosphorylation System in Cardiac Mitochondria. Int. J. Mol. Sci. 2021, 22, 1462. [Google Scholar] [CrossRef]
- Lu, Y.W.; Acoba, M.G.; Selvaraju, K.; Huang, T.C.; Nirujogi, R.S.; Sathe, G.; Pandey, A.; Claypool, S.M. Human adenine nucleotide translocases physically and functionally interact with respirasomes. Mol. Biol. Cell 2017, 28, 1489–1506. [Google Scholar] [CrossRef] [PubMed]
- M. Parodi-Rullán, R.; Chapa-Dubocq, X.; Guzmán-Hernández, R.; Jang, S.; A. Torres-Ramos, C.; Ayala-Peña, S.; Javadov, S. The Role of Adenine Nucleotide Translocase in the Assembly of Respiratory Supercomplexes in Cardiac Cells. Cells 2019, 8, 1247. [Google Scholar] [CrossRef]
- Roussel, D.; Roussel, N.; Voituron, Y.; Rey, B. Liver mitochondrial coupling efficiency and its relationship to oxidative capacity and adenine nucleotide translocase content: A comparative study among crocodiles, birds and mammals. Mitochondrion 2024, 78, 101909. [Google Scholar] [CrossRef]
- Belosludtseva, N.V.; Ilzorkina, A.I.; Serov, D.A.; Dubinin, M.V.; Talanov, E.Y.; Karagyaur, M.N.; Primak, A.L.; Liu, J.; Belosludtsev, K.N. ANT-Mediated Inhibition of the Permeability Transition Pore Alleviates Palmitate-Induced Mitochondrial Dysfunction and Lipotoxicity. Biomolecules 2024, 14, 1159. [Google Scholar] [CrossRef]
- Kreiter, J.; Rupprecht, A.; Škulj, S.; Brkljača, Z.; Žuna, K.; Knyazev, D.G.; Bardakji, S.; Vazdar, M.; Pohl, E.E. ANT1 Activation and Inhibition Patterns Support the Fatty Acid Cycling Mechanism for Proton Transport. Int. J. Mol. Sci. 2021, 22, 2490. [Google Scholar] [CrossRef]
- Schönfeld, P.; Wojtczak, L. Short- and medium-chain fatty acids in energy metabolism: The cellular perspective. J. Lipid Res. 2016, 57, 943–954. [Google Scholar] [CrossRef]
- Bevilacqua, L.; Seifert, E.L.; Estey, C.; Gerrits, M.F.; Harper, M.E. Absence of uncoupling protein-3 leads to greater activation of an adenine nucleotide translocase-mediated proton conductance in skeletal muscle mitochondria from calorie restricted mice. Biochim. Biophys. Acta 2010, 1797, 1389–1397. [Google Scholar] [CrossRef] [PubMed]
- Friederich, M.; Nordquist, L.; Olerud, J.; Johansson, M.; Hansell, P.; Palm, F. Identification and distribution of uncoupling protein isoforms in the normal and diabetic rat kidney. Adv. Exp. Med. Biol. 2009, 645, 205–212. [Google Scholar] [CrossRef]
- Brand, M.D.; Pakay, J.L.; Ocloo, A.; Kokoszka, J.; Wallace, D.C.; Brookes, P.S.; Cornwall, E.J. The basal proton conductance of mitochondria depends on adenine nucleotide translocase content. Biochem. J. 2005, 392, 353–362. [Google Scholar] [CrossRef]
- Schiffer, T.A.; Löf, L.; Gallini, R.; Kamali-Moghaddam, M.; Carlström, M.; Palm, F. Mitochondrial Respiration-Dependent ANT2-UCP2 Interaction. Front. Physiol. 2022, 13, 866590. [Google Scholar] [CrossRef]
- Chen, Y.; Liu, J.; Zheng, Y.; Wang, J.; Wang, Z.; Gu, S.; Tan, J.; Jing, Q.; Yang, H. Uncoupling protein 3 mediates H2O2 preconditioning-afforded cardioprotection through the inhibition of MPTP opening. Cardiovasc. Res. 2015, 105, 192–202. [Google Scholar] [CrossRef]
- Schulz, R.; Schluter, K.D. Importance of Mitochondria in Cardiac Pathologies: Focus on Uncoupling Proteins and Monoamine Oxidases. Int. J. Mol. Sci. 2023, 24, 6459. [Google Scholar] [CrossRef]
- Dörner, A.; Lynetskiy, O.; Euler, G.; Landmesser, U.; Schlüter, K.D.; Heger, J. Mitochondria Isolated from Hearts Subjected to Ischemia/Reperfusion Benefit from Adenine Nucleotide Translocase 1 Overexpression. Membranes 2021, 11, 836. [Google Scholar] [CrossRef] [PubMed]
- Chen, J.J.; Bertrand, H.; Yu, B.P. Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Radic. Biol. Med. 1995, 19, 583–590. [Google Scholar] [CrossRef] [PubMed]
- Eaton, P.; Li, J.M.; Hearse, D.J.; Shattock, M.J. Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am. J. Physiol. 1999, 276, H935–H943. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Zwizinski, C.W.; Schmid, H.H. Peroxidative damage to cardiac mitochondria: Identification and purification of modified adenine nucleotide translocase. Arch. Biochem. Biophys. 1992, 294, 178–183. [Google Scholar] [CrossRef]
- Vieira, H.L.; Belzacq, A.S.; Haouzi, D.; Bernassola, F.; Cohen, I.; Jacotot, E.; Ferri, K.F.; El Hamel, C.; Bartle, L.M.; Melino, G.; et al. The adenine nucleotide translocator: A target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 2001, 20, 4305–4316. [Google Scholar] [CrossRef]
- Klumpe, I.; Savvatis, K.; Westermann, D.; Tschope, C.; Rauch, U.; Landmesser, U.; Schultheiss, H.P.; Dorner, A. Transgenic overexpression of adenine nucleotide translocase 1 protects ischemic hearts against oxidative stress. J. Mol. Med. 2016, 94, 645–653. [Google Scholar] [CrossRef] [PubMed]
- Yan, L.J.; Sohal, R.S. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc. Natl. Acad. Sci. USA 1998, 95, 12896–12901. [Google Scholar] [CrossRef] [PubMed]
- Jovanović, O.; Chekashkina, K.; Škulj, S.; Žuna, K.; Vazdar, M.; Bashkirov, P.V.; Pohl, E.E. Membrane Lipid Reshaping Underlies Oxidative Stress Sensing by the Mitochondrial Proteins UCP1 and ANT1. Antioxidants 2022, 11, 2314. [Google Scholar] [CrossRef]
- Brustovetsky, N. The Role of Adenine Nucleotide Translocase in the Mitochondrial Permeability Transition. Cells 2020, 9, 2686. [Google Scholar] [CrossRef]
- Winter, J.; Klumpe, I.; Heger, J.; Rauch, U.; Schultheiss, H.P.; Landmesser, U.; Dorner, A. Adenine nucleotide translocase 1 overexpression protects cardiomyocytes against hypoxia via increased ERK1/2 and AKT activation. Cell Signal 2016, 28, 152–159. [Google Scholar] [CrossRef]
- Liu, J.; Ding, W.; Chen, Q.; Peng, Y.; Kong, Y.; Ma, L.; Zhang, W. Adenine Nucleotide Translocase 1 Promotes Functional Integrity of Mitochondria via Activating DDIT3-CytC Pathway and Intensifying Actin Filament Structures. Mol. Neurobiol. 2025, 62, 8457–8474. [Google Scholar] [CrossRef]
- Beutner, G.; Rück, A.; Riede, B.; Brdiczka, D. Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim. Biophys. Acta 1998, 1368, 7–18. [Google Scholar] [CrossRef]
- Brustovetsky, N.; Tropschug, M.; Heimpel, S.; Heidkämper, D.; Klingenberg, M. A large Ca2+-dependent channel formed by recombinant ADP/ATP carrier from Neurospora crassa resembles the mitochondrial permeability transition pore. Biochemistry 2002, 41, 11804–11811. [Google Scholar] [CrossRef]
- Bernardi, P. Mechanisms for Ca2+-dependent permeability transition in mitochondria. Proc. Natl. Acad. Sci. USA 2020, 117, 2743–2744. [Google Scholar] [CrossRef] [PubMed]
- McEnery, M.W.; Snowman, A.M.; Trifiletti, R.R.; Snyder, S.H. Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. USA 1992, 89, 3170–3174. [Google Scholar] [CrossRef] [PubMed]
- Kokoszka, J.E.; Waymire, K.G.; Levy, S.E.; Sligh, J.E.; Cai, J.; Jones, D.P.; MacGregor, G.R.; Wallace, D.C. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004, 427, 461–465. [Google Scholar] [CrossRef]
- Karch, J.; Bround, M.J.; Khalil, H.; Sargent, M.A.; Latchman, N.; Terada, N.; Peixoto, P.M.; Molkentin, J.D. Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. Sci. Adv. 2019, 5, eaaw4597. [Google Scholar] [CrossRef]
- Bernardi, P.; Gerle, C.; Halestrap, A.P.; Jonas, E.A.; Karch, J.; Mnatsakanyan, N.; Pavlov, E.; Sheu, S.S.; Soukas, A.A. Identity, structure, and function of the mitochondrial permeability transition pore: Controversies, consensus, recent advances, and future directions. Cell Death Differ. 2023, 30, 1869–1885. [Google Scholar] [CrossRef]
- Alavian, K.N.; Beutner, G.; Lazrove, E.; Sacchetti, S.; Park, H.A.; Licznerski, P.; Li, H.; Nabili, P.; Hockensmith, K.; Graham, M.; et al. An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc. Natl. Acad. Sci. USA 2014, 111, 10580–10585. [Google Scholar] [CrossRef] [PubMed]
- Pekson, R.; Liang, F.G.; Axelrod, J.L.; Lee, J.; Qin, D.; Wittig, A.J.H.; Paulino, V.M.; Zheng, M.; Peixoto, P.M.; Kitsis, R.N. The mitochondrial ATP synthase is a negative regulator of the mitochondrial permeability transition pore. Proc. Natl. Acad. Sci. USA 2023, 120, e2303713120. [Google Scholar] [CrossRef]
- Ban, T.; Ishihara, T.; Kohno, H.; Saita, S.; Ichimura, A.; Maenaka, K.; Oka, T.; Mihara, K.; Ishihara, N. Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin. Nat. Cell Biol. 2017, 19, 856–863. [Google Scholar] [CrossRef] [PubMed]
- Chen, H.; Chan, D.C. Mitochondrial dynamics in mammals. Curr. Top. Dev. Biol. 2004, 59, 119–144. [Google Scholar] [CrossRef]
- Mishra, P.; Carelli, V.; Manfredi, G.; Chan, D.C. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell Metab. 2014, 19, 630–641. [Google Scholar] [CrossRef]
- Schlattner, U.; Tokarska-Schlattner, M.; Epand, R.M.; Boissan, M.; Lacombe, M.L.; Kagan, V.E. NME4/nucleoside diphosphate kinase D in cardiolipin signaling and mitophagy. Lab. Investig. 2018, 98, 228–232. [Google Scholar] [CrossRef] [PubMed]
- Donnarumma, E.; Kohlhaas, M.; Vimont, E.; Kornobis, E.; Chaze, T.; Gianetto, Q.G.; Matondo, M.; Moya-Nilges, M.; Maack, C.; Wai, T. Mitochondrial Fission Process 1 controls inner membrane integrity and protects against heart failure. Nat. Commun. 2022, 13, 6634. [Google Scholar] [CrossRef]
- Picca, A.; Mankowski, R.T.; Burman, J.L.; Donisi, L.; Kim, J.S.; Marzetti, E.; Leeuwenburgh, C. Mitochondrial quality control mechanisms as molecular targets in cardiac ageing. Nat. Rev. Cardiol. 2018, 15, 543–554. [Google Scholar] [CrossRef] [PubMed]
- Eldeeb, M.A.; Fallahi, A.; Soumbasis, A.; Bayne, A.N.; Trempe, J.F.; Fon, E.A. Mitochondrial import stress and PINK1-mediated mitophagy: The role of the PINK1-TOMM-TIMM23 supercomplex. Autophagy 2024, 20, 1903–1905. [Google Scholar] [CrossRef]
- Pickles, S.; Vigie, P.; Youle, R.J. Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance. Curr. Biol. 2018, 28, R170–R185. [Google Scholar] [CrossRef]
- Onishi, M.; Yamano, K.; Sato, M.; Matsuda, N.; Okamoto, K. Molecular mechanisms and physiological functions of mitophagy. EMBO J. 2021, 40, e104705. [Google Scholar] [CrossRef]
- Hoshino, A.; Wang, W.J.; Wada, S.; McDermott-Roe, C.; Evans, C.S.; Gosis, B.; Morley, M.P.; Rathi, K.S.; Li, J.; Li, K.; et al. The ADP/ATP translocase drives mitophagy independent of nucleotide exchange. Nature 2019, 575, 375–379. [Google Scholar] [CrossRef]
- Greene, A.W.; Grenier, K.; Aguileta, M.A.; Muise, S.; Farazifard, R.; Haque, M.E.; McBride, H.M.; Park, D.S.; Fon, E.A. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 2012, 13, 378–385. [Google Scholar] [CrossRef]
- Jiang, S.; Chen, D.; Sheng, R.; Yuan, Q.; Pan, J.; Guo, Y. USP34 attenuates cartilage degradation in temporomandibular joint osteoarthritis by ANT1-mediated mitophagy. JBMR Plus 2026, 10, ziag004. [Google Scholar] [CrossRef]
- Tang, X.; Zhao, S.; Liu, J.; Liu, X.; Sha, X.; Huang, C.; Hu, L.; Sun, S.; Gao, Y.; Chen, H.; et al. Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation. Circ. Res. 2023, 133, 220–236. [Google Scholar] [CrossRef] [PubMed]
- Li, N.; Xu, H.; Liu, X.; Gao, R.; He, J.; Ding, Y.; Li, F.; Geng, Y.; Mu, X.; Chen, X. Exposure to benzo(a)pyrene suppresses mitophagy via ANT1-PINK1-Parkin pathway in ovarian corpus luteum during early pregnancy. Sci. Total Environ. 2022, 814, 152759. [Google Scholar] [CrossRef]
- Wang, N.; Li, W.; Yang, T.; Li, B.; Meng, C.; Zhou, X.; Sun, J.; Yu, K.; Cui, S.; Cao, R. Targeting CB1R Rewires Ca2+-Dependent Mitophagy to Promote Nerve Regeneration. Theranostics 2025, 15, 8873–8896. [Google Scholar] [CrossRef] [PubMed]
- Hu, K.; Lai, Y.; Zhou, J.; Hu, C.; Guo, S.; Zhang, H.; Wang, G.; Zhang, Q.; Gao, X.; Wang, Z.; et al. Aberrant activation of adenine nucleotide translocase 3 promotes progression and chemoresistance in multiple myeloma dependent on PINK1 transport. Int. J. Biol. Sci. 2025, 21, 233–250. [Google Scholar] [CrossRef]
- Ferramosca, A.; Zara, V. Biogenesis of mitochondrial carrier proteins: Molecular mechanisms of import into mitochondria. Biochim. Biophys. Acta 2013, 1833, 494–502. [Google Scholar] [CrossRef] [PubMed]
- Coyne, L.P.; Wang, X.; Song, J.; de Jong, E.; Schneider, K.; Massa, P.T.; Middleton, F.A.; Becker, T.; Chen, X.J. Mitochondrial protein import clogging as a mechanism of disease. eLife 2023, 12, e84330. [Google Scholar] [CrossRef] [PubMed]
- Fontanesi, F.; Palmieri, L.; Scarcia, P.; Lodi, T.; Donnini, C.; Limongelli, A.; Tiranti, V.; Zeviani, M.; Ferrero, I.; Viola, A.M. Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability. Hum. Mol. Genet. 2004, 13, 923–934. [Google Scholar] [CrossRef] [PubMed]
- Kaukonen, J.; Juselius, J.K.; Tiranti, V.; Kyttälä, A.; Zeviani, M.; Comi, G.P.; Keränen, S.; Peltonen, L.; Suomalainen, A. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000, 289, 782–785. [Google Scholar] [CrossRef]
- Palmieri, L.; Alberio, S.; Pisano, I.; Lodi, T.; Meznaric-Petrusa, M.; Zidar, J.; Santoro, A.; Scarcia, P.; Fontanesi, F.; Lamantea, E.; et al. Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum. Mol. Genet. 2005, 14, 3079–3088. [Google Scholar] [CrossRef]
- Wang, X.; Salinas, K.; Zuo, X.; Kucejova, B.; Chen, X.J. Dominant membrane uncoupling by mutant adenine nucleotide translocase in mitochondrial diseases. Hum. Mol. Genet. 2008, 17, 4036–4044. [Google Scholar] [CrossRef]
- Esposito, L.A.; Melov, S.; Panov, A.; Cottrell, B.A.; Wallace, D.C. Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl. Acad. Sci. USA 1999, 96, 4820–4825. [Google Scholar] [CrossRef]
- Lee, S.R.; Han, J. Mitochondrial Nucleoid: Shield and Switch of the Mitochondrial Genome. Oxidative Med. Cell. Longev. 2017, 2017, 8060949. [Google Scholar] [CrossRef]
- Bogenhagen, D.F.; Wang, Y.; Shen, E.L.; Kobayashi, R. Protein components of mitochondrial DNA nucleoids in higher eukaryotes. Mol. Cell Proteom. 2003, 2, 1205–1216. [Google Scholar] [CrossRef]
- Kasashima, K.; Ohta, E.; Kagawa, Y.; Endo, H. Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2. J. Biol. Chem. 2006, 281, 36401–36410. [Google Scholar] [CrossRef]
- Kuramori, C.; Azuma, M.; Kume, K.; Kaneko, Y.; Inoue, A.; Yamaguchi, Y.; Kabe, Y.; Hosoya, T.; Kizaki, M.; Suematsu, M.; et al. Capsaicin binds to prohibitin 2 and displaces it from the mitochondria to the nucleus. Biochem. Biophys. Res. Commun. 2009, 379, 519–525. [Google Scholar] [CrossRef]
- Ito, K.; Nakazato, T.; Yamato, K.; Miyakawa, Y.; Yamada, T.; Hozumi, N.; Segawa, K.; Ikeda, Y.; Kizaki, M. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: Implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res. 2004, 64, 1071–1078. [Google Scholar] [CrossRef]
- Alula, K.M.; Delgado-Deida, Y.; Callahan, R.; Till, A.; Underwood, L.; Thompson, W.E.; Souza, R.F.; Dassopoulos, T.; Onyiah, J.; Venuprasad, K.; et al. Inner mitochondrial membrane protein Prohibitin 1 mediates Nix-induced, Parkin-independent mitophagy. Sci. Rep. 2023, 13, 18. [Google Scholar] [CrossRef] [PubMed]
- Merkwirth, C.; Langer, T. Prohibitin function within mitochondria: Essential roles for cell proliferation and cristae morphogenesis. Biochim. Biophys. Acta 2009, 1793, 27–32. [Google Scholar] [CrossRef] [PubMed]
- Kobayashi, H.; Miura, T.; Ishida, H.; Miki, T.; Tanno, M.; Yano, T.; Sato, T.; Hotta, H.; Shimamoto, K. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion. Clin. Exp. Pharmacol. Physiol. 2008, 35, 812–819. [Google Scholar] [CrossRef] [PubMed]
- Das, S.; Wong, R.; Rajapakse, N.; Murphy, E.; Steenbergen, C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ. Res. 2008, 103, 983–991. [Google Scholar] [CrossRef]
- Zhai, P.; Sadoshima, J. Overcoming an energy crisis?: An adaptive role of glycogen synthase kinase-3 inhibition in ischemia/reperfusion. Circ. Res. 2008, 103, 910–913. [Google Scholar] [CrossRef]
- Jang, J.Y.; Jeon, Y.K.; Kim, C.W. Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. BMC Cancer 2010, 10, 391. [Google Scholar] [CrossRef] [PubMed]
- Yergoz, F.; Friebel, J.; Krankel, N.; Rauch-Kroehnert, U.; Schultheiss, H.P.; Landmesser, U.; Dorner, A. Adenine Nucleotide Translocase 1 Expression Modulates the Immune Response in Ischemic Hearts. Cells 2021, 10, 2130. [Google Scholar] [CrossRef]
- Feng, J.; Lucchinetti, E.; Enkavi, G.; Wang, Y.; Gehrig, P.; Roschitzki, B.; Schaub, M.C.; Tajkhorshid, E.; Zaugg, K.; Zaugg, M. Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria. Am. J. Physiol. Cell Physiol. 2010, 298, C740–C748. [Google Scholar] [CrossRef]
- Hsu, P.C.; Yang, C.T.; Jablons, D.M.; You, L. The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC). Cancers 2020, 12, 1361. [Google Scholar] [CrossRef] [PubMed]
- Gavaldà-Navarro, A.; Villena, J.A.; Planavila, A.; Viñas, O.; Mampel, T. Expression of adenine nucleotide translocase (ANT) isoform genes is controlled by PGC-1α through different transcription factors. J. Cell Physiol. 2014, 229, 2126–2136. [Google Scholar] [CrossRef] [PubMed]
- Li, T.; Li, Y.; Liu, T.; Hu, B.; Li, J.; Liu, C.; Liu, T.; Li, F. Mitochondrial PAK6 inhibits prostate cancer cell apoptosis via the PAK6-SIRT4-ANT2 complex. Theranostics 2020, 10, 2571–2586. [Google Scholar] [CrossRef] [PubMed]
- Ihara, Y.; Suzuki, Y.J.; Kitta, K.; Jones, L.R.; Ikeda, T. Modulation of gene expression in transgenic mouse hearts overexpressing calsequestrin. Cell Calcium 2002, 32, 21–29. [Google Scholar] [CrossRef]
- Roussel, J.; Thireau, J.; Brenner, C.; Saint, N.; Scheuermann, V.; Lacampagne, A.; Le Guennec, J.Y.; Fauconnier, J. Palmitoyl-carnitine increases RyR2 oxidation and sarcoplasmic reticulum Ca2+ leak in cardiomyocytes: Role of adenine nucleotide translocase. Biochim. Biophys. Acta 2015, 1852, 749–758. [Google Scholar] [CrossRef]
- Yamaguchi, N.; Kagari, T.; Kasai, M. Inhibition of the ryanodine receptor calcium channel in the sarcoplasmic reticulum of skeletal muscle by an ADP/ATP translocase inhibitor, atractyloside. Biochem. Biophys. Res. Commun. 1999, 258, 247–251. [Google Scholar] [CrossRef]
- Vogelpohl, I.; Vetter, R.; Heger, J.; Ebermann, L.; Euler, G.; Schultheiss, H.P.; Dorner, A. Transgenic overexpression of heart-specific adenine nucleotide translocase 1 positively affects contractile function in cardiomyocytes. Cell Physiol. Biochem. 2011, 27, 121–128. [Google Scholar] [CrossRef]
- Walther, T.; Tschope, C.; Sterner-Kock, A.; Westermann, D.; Heringer-Walther, S.; Riad, A.; Nikolic, A.; Wang, Y.; Ebermann, L.; Siems, W.E.; et al. Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease. Circulation 2007, 115, 333–344. [Google Scholar] [CrossRef]
- Wang, Y.; Ebermann, L.; Sterner-Kock, A.; Wika, S.; Schultheiss, H.P.; Dorner, A.; Walther, T. Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice. Exp. Physiol. 2009, 94, 220–227. [Google Scholar] [CrossRef]
- Wang, K.; Long, B.; Li, N.; Li, L.; Liu, C.Y.; Dong, Y.H.; Gao, J.N.; Zhou, L.Y.; Wang, C.Q.; Li, P.F. MicroRNA-2861 regulates programmed necrosis in cardiomyocyte by impairing adenine nucleotide translocase 1 expression. Free Radic. Biol. Med. 2016, 91, 58–67. [Google Scholar] [CrossRef]
- Kriegel, A.J.; Terhune, S.S.; Greene, A.S.; Noon, K.R.; Pereckas, M.S.; Liang, M. Isomer-specific effect of microRNA miR-29b on nuclear morphology. J. Biol. Chem. 2018, 293, 14080–14088. [Google Scholar] [CrossRef] [PubMed]
- Jang, J.Y.; Lee, Y.S.; Jeon, Y.K.; Lee, K.; Jang, J.J.; Kim, C.W. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma. Exp. Mol. Med. 2013, 45, e3. [Google Scholar] [CrossRef] [PubMed]
- Jang, J.Y.; Jeon, Y.K.; Lee, C.E.; Kim, C.W. ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression. Int. J. Oncol. 2013, 42, 574–582. [Google Scholar] [CrossRef]
- Baik, S.H.; Lee, J.; Lee, Y.S.; Jang, J.Y.; Kim, C.W. ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells. Exp. Mol. Med. 2016, 48, e222. [Google Scholar] [CrossRef] [PubMed]
- Jang, J.Y.; Kim, Y.G.; Nam, S.J.; Keam, B.; Kim, T.M.; Jeon, Y.K.; Kim, C.W. Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer. Mol. Cancer Ther. 2016, 15, 1387–1396. [Google Scholar] [CrossRef]
- Lu, A.Q.; Lv, B.; Qiu, F.; Wang, X.Y.; Cao, X.H. Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma. Oncol. Rep. 2017, 37, 2071–2078. [Google Scholar] [CrossRef]
- Guo, X.; Huang, Y.; Qi, Y.; Liu, Z.; Ma, Y.; Shao, Y.; Jiang, S.; Sun, Z.; Ruan, Q. Human cytomegalovirus miR-UL36-5p inhibits apoptosis via downregulation of adenine nucleotide translocator 3 in cultured cells. Arch. Virol. 2015, 160, 2483–2490. [Google Scholar] [CrossRef]
- Jang, J.Y.; Lee, C.E. IL-4-induced upregulation of adenine nucleotide translocase 3 and its role in Th cell survival from apoptosis. Cell Immunol. 2006, 241, 14–25. [Google Scholar] [CrossRef]
- Kretova, M.; Sabova, L.; Hodny, Z.; Bartek, J.; Kollarovic, G.; Nelson, B.D.; Hubackova, S.; Luciakova, K. TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence. Cell Signal 2014, 26, 2903–2911. [Google Scholar] [CrossRef]
- Heger, J.; Abdallah, Y.; Shahzad, T.; Klumpe, I.; Piper, H.M.; Schultheiss, H.P.; Schluter, K.D.; Schulz, R.; Euler, G.; Dorner, A. Transgenic overexpression of the adenine nucleotide translocase 1 protects cardiomyocytes against TGFbeta1-induced apoptosis by stabilization of the mitochondrial permeability transition pore. J. Mol. Cell Cardiol. 2012, 53, 73–81. [Google Scholar] [CrossRef] [PubMed]
- Guo, W.; Liu, W.; Chen, Z.; Gu, Y.; Peng, S.; Shen, L.; Shen, Y.; Wang, X.; Feng, G.S.; Sun, Y.; et al. Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis. Nat. Commun. 2017, 8, 2168. [Google Scholar] [CrossRef]
- Zhao, Y.; Shi, F.; Hao, H.; Wang, Z.; Li, J.; Liu, B.; Niu, Y.; Wang, W.; Zhang, Y. Hypertension Increases Susceptibility to Lead-Induced Microglial Polarization via ANT1-Mediated Mitochondrial DNA/cGAS/STING Signaling. Research 2025, 8, 1026. [Google Scholar] [CrossRef] [PubMed]
- Wang, P.; Zhang, L.; Chen, S.; Li, R.; Liu, P.; Li, X.; Luo, H.; Huo, Y.; Zhang, Z.; Cai, Y.; et al. ANT2 functions as a translocon for mitochondrial cross-membrane translocation of RNAs. Cell Res. 2024, 34, 504–521. [Google Scholar] [CrossRef]
- Zhu, H.; Lin, W.; Lin, A. ANT2: The first mammalian mitochondrial RNA transport translocon. Cell Res. 2024, 34, 535–536. [Google Scholar] [CrossRef]
- Jiang, H.; Jiang, Y.; Dong, R.; Fu, C.Y. ETS2 aggravate allergic airway inflammation by regulating ANT2-mediated cytosolic mitochondrial DsRNA levels. Respir. Res. 2025, 26, 159. [Google Scholar] [CrossRef]
- Wang, G.; Chen, H.W.; Oktay, Y.; Zhang, J.; Allen, E.L.; Smith, G.M.; Fan, K.C.; Hong, J.S.; French, S.W.; McCaffery, J.M.; et al. PNPASE regulates RNA import into mitochondria. Cell 2010, 142, 456–467. [Google Scholar] [CrossRef] [PubMed]
- Krieger, M.R.; Abrahamian, M.; He, K.L.; Atamdede, S.; Hakimjavadi, H.; Momcilovic, M.; Ostrow, D.; Maggo, S.D.; Tsang, Y.P.; Gai, X.; et al. Trafficking of mitochondrial double-stranded RNA from mitochondria to the cytosol. Life Sci. Alliance 2024, 7, 202302396. [Google Scholar] [CrossRef]
- Belzacq, A.S.; Vieira, H.L.; Verrier, F.; Vandecasteele, G.; Cohen, I.; Prevost, M.C.; Larquet, E.; Pariselli, F.; Petit, P.X.; Kahn, A.; et al. Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res. 2003, 63, 541–546. [Google Scholar]
- Yosef, O.; Cohen-Daniel, L.; Shamriz, O.; Bar-On, Z.; Salaymeh, W.; Saragovi, A.; Abramovich, I.; Agranovich, B.; Lutz, V.; Tam, J.; et al. Metabolic reprogramming driven by Ant2 deficiency augments T Cell function and anti-tumor immunity in mice. Nat. Commun. 2025, 16, 4292. [Google Scholar] [CrossRef]
- Zhu, G.; Yu, H.; Li, X.; Ye, W.; Chen, X.; Gu, W. CD147 mitochondria translocation induced airway remodeling in asthmatic mouse models by regulating M2 macrophage polarization via ANT1-mediated mitophagy. Am. J. Physiol. Cell Physiol. 2025, 328, C604–C616. [Google Scholar] [CrossRef]
- Seo, J.B.; Riopel, M.; Cabrales, P.; Huh, J.Y.; Bandyopadhyay, G.K.; Andreyev, A.Y.; Murphy, A.N.; Beeman, S.C.; Smith, G.I.; Klein, S.; et al. Knockdown of Ant2 Reduces Adipocyte Hypoxia and Improves Insulin Resistance in Obesity. Nat. Metab. 2019, 1, 86–97. [Google Scholar] [CrossRef]
- Sigal, C.T.; Resh, M.D. The ADP/ATP carrier is the 32-kilodalton receptor for an NH2-terminally myristylated src peptide but not for pp60src polypeptide. Mol. Cell Biol. 1993, 13, 3084–3092. [Google Scholar] [CrossRef][Green Version]
- Cardouat, G.; Duparc, T.; Fried, S.; Perret, B.; Najib, S.; Martinez, L.O. Ectopic adenine nucleotide translocase activity controls extracellular ADP levels and regulates the F(1)-ATPase-mediated HDL endocytosis pathway on hepatocytes. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2017, 1862, 832–841. [Google Scholar] [CrossRef]
- Radichev, I.A.; Remacle, A.G.; Sounni, N.E.; Shiryaev, S.A.; Rozanov, D.V.; Zhu, W.; Golubkova, N.V.; Postnova, T.I.; Golubkov, V.S.; Strongin, A.Y. Biochemical evidence of the interactions of membrane type-1 matrix metalloproteinase (MT1-MMP) with adenine nucleotide translocator (ANT): Potential implications linking proteolysis with energy metabolism in cancer cells. Biochem. J. 2009, 420, 37–47. [Google Scholar] [CrossRef][Green Version]
- Loers, G.; Makhina, T.; Bork, U.; Dörner, A.; Schachner, M.; Kleene, R. The interaction between cell adhesion molecule L1, matrix metalloproteinase 14, and adenine nucleotide translocator at the plasma membrane regulates L1-mediated neurite outgrowth of murine cerebellar neurons. J. Neurosci. 2012, 32, 3917–3930. [Google Scholar] [CrossRef]
- Kliment, C.R.; Nguyen, J.M.K.; Kaltreider, M.J.; Lu, Y.; Claypool, S.M.; Radder, J.E.; Sciurba, F.C.; Zhang, Y.; Gregory, A.D.; Iglesias, P.A.; et al. Adenine nucleotide translocase regulates airway epithelial metabolism, surface hydration and ciliary function. J. Cell Sci. 2021, 134, jcs257162. [Google Scholar] [CrossRef] [PubMed]
- Marginedas-Freixa, I.; Alvarez, C.L.; Moras, M.; Leal Denis, M.F.; Hattab, C.; Halle, F.; Bihel, F.; Mouro-Chanteloup, I.; Lefevre, S.D.; Le Van Kim, C.; et al. Human erythrocytes release ATP by a novel pathway involving VDAC oligomerization independent of pannexin-1. Sci. Rep. 2018, 8, 11384. [Google Scholar] [CrossRef] [PubMed]
- Winkler, H.H. Rickettsial permeability. An ADP-ATP transport system. J. Biol. Chem. 1976, 251, 389–396. [Google Scholar] [CrossRef]
- D’Ambrosio, A.; Zamboni, S.; Camerini, S.; Casella, M.; Sanchez, M.; Pietraforte, D.; Vanacore, N.; Diociauti, M.; Altieri, M.; Di Piero, V.; et al. Proteomic profile of extracellular vesicles from plasma and CSF of multiple sclerosis patients reveals disease activity-associated EAAT2. J. Neuroinflamm. 2024, 21, 217. [Google Scholar] [CrossRef] [PubMed]
- Gangoda, L.; Liem, M.; Ang, C.S.; Keerthikumar, S.; Adda, C.G.; Parker, B.S.; Mathivanan, S. Proteomic Profiling of Exosomes Secreted by Breast Cancer Cells with Varying Metastatic Potential. Proteomics 2017, 17, 1600370. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.S.; Jeong, J.; Lee, K.J. Characterization of vesicles secreted from insulinoma NIT-1 cells. J. Proteome Res. 2009, 8, 2851–2862. [Google Scholar] [CrossRef] [PubMed]
- Soubannier, V.; McLelland, G.L.; Zunino, R.; Braschi, E.; Rippstein, P.; Fon, E.A.; McBride, H.M. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr. Biol. 2012, 22, 135–141. [Google Scholar] [CrossRef] [PubMed]
- Chamberlain, K.A.; Huang, N.; Xie, Y.; LiCausi, F.; Li, S.; Li, Y.; Sheng, Z.H. Oligodendrocytes enhance axonal energy metabolism by deacetylation of mitochondrial proteins through transcellular delivery of SIRT2. Neuron 2021, 109, 3456–3472.e3458. [Google Scholar] [CrossRef] [PubMed]






| Effector | ANT Isoform | Mechanism of Action |
|---|---|---|
| miR-2861 | ANT1 | Direct binding to ANT1 coding sequence; suppresses ANT1 expression and sensitizes cardiomyocytes to necrotic cell death under oxidative stress |
| miR-29b | ANT2 | Physical association with ANT2; co-localizes in perinuclear clusters and regulates nuclear morphology and mitotic progression |
| miR-636 | ANT2 | Induced upon ANT2 suppression; targets Ras and inhibits proliferation in hepatocellular carcinoma |
| miR-19a | ANT2 | Reduced after ANT2 knockdown; modulates SOCS1/STAT3 signaling and oncogenic pathways |
| miR-96 | ANT2 | Downregulated upon ANT2 inhibition; contributes to suppression of tumor-promoting signaling |
| miR-21 | ANT2 | Reduced after ANT2 knockdown; restores SOCS1 expression and attenuates PI3K/AKT signaling |
| miR-221/222 | ANT2 | Downregulated after ANT2 suppression; limits STAT3-driven oncogenic signaling |
| miR-137 | ANT2 | Restoration reverses ANT2-driven cancer stemness and metastasis in HCC models |
| hcmv-miR-UL36-5p | ANT3 | Viral miRNA suppresses ANT3 expression, inhibits apoptosis, and promotes viral persistence |
| TNFα | ANT1 | NF-κB–dependent transcriptional repression; promotes ΔΨm loss, ROS production, and necrotic cell death |
| IL-6 | ANT1 | Suppresses ANT1 expression via inflammatory signaling pathways |
| IL-1β | ANT1 | Downregulates ANT1 expression and enhances mitochondrial dysfunction |
| Interferons (type I) | ANT1 | Repress ANT1 expression through inflammatory transcriptional programs |
| IL-4 | ANT1 | Induces ANT1 expression via tyrosine kinase, PI3K/AKT, ERK, and NF-κB signaling |
| IL-4 | ANT3 | Induces ANT3 expression in human T cells and promotes anti-apoptotic signaling |
| IFN-γ | ANT3 | STAT1-dependent induction of ANT3; antagonized by IL-4/STAT6 signaling |
| TGF-β | ANT2 | NF1/Smad4 repressor complex binds ANT2 promoter and suppresses transcription in senescent cells |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Rauch-Kroehnert, U.; Heger, J.; Landmesser, U.; Dörner, A. Adenine Nucleotide Translocase: From Nucleotide Carrier to a Modulator of Mitochondrial Bioenergetics, Quality Control, and Cellular Communication. Cells 2026, 15, 646. https://doi.org/10.3390/cells15070646
Rauch-Kroehnert U, Heger J, Landmesser U, Dörner A. Adenine Nucleotide Translocase: From Nucleotide Carrier to a Modulator of Mitochondrial Bioenergetics, Quality Control, and Cellular Communication. Cells. 2026; 15(7):646. https://doi.org/10.3390/cells15070646
Chicago/Turabian StyleRauch-Kroehnert, Ursula, Jacqueline Heger, Ulf Landmesser, and Andrea Dörner. 2026. "Adenine Nucleotide Translocase: From Nucleotide Carrier to a Modulator of Mitochondrial Bioenergetics, Quality Control, and Cellular Communication" Cells 15, no. 7: 646. https://doi.org/10.3390/cells15070646
APA StyleRauch-Kroehnert, U., Heger, J., Landmesser, U., & Dörner, A. (2026). Adenine Nucleotide Translocase: From Nucleotide Carrier to a Modulator of Mitochondrial Bioenergetics, Quality Control, and Cellular Communication. Cells, 15(7), 646. https://doi.org/10.3390/cells15070646

